Chemical classes categorized as Fpr-rs6 inhibitors consist of diverse compounds that act upon the signaling pathways and cellular processes potentially linked to the Fpr-rs6 protein. These substances interact with different molecular targets that are part of or connected to the signaling networks in which Fpr-rs6 participates. As Fpr-rs6 is a GPCR, its primary function is to transduce extracellular signals into cellular responses, commonly through the activation of downstream G proteins and subsequent signaling cascades. Inhibitors like Boc-MLF and WRW4 target related GPCRs, presuming that their antagonistic effects can extend to Fpr-rs6 by preventing ligand-receptor interactions and receptor activation.
Other molecules such as Cyclosporin A and Pertussis Toxin alter the activity of proteins involved in secondary messenger systems, such as calcineurin and the Gi protein of GPCRs, respectively. These alterations can attenuate or modify the signal transduction processes that Fpr-rs6 might initiate or modulate. Additionally, compounds like PD 98059, LY294002, and Wortmannin intervene in kinase signaling pathways, specifically targeting MEK, PI3K, and related enzymes, which are often downstream effectors in GPCR-mediated signaling. Their inhibitory action on these kinases can result in the modulation of various cellular responses, potentially including those orchestrated by Fpr-rs6.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A, an immunosuppressant, can inhibit calcineurin and thus may affect Fpr-rs6 related pathways that involve calcium signaling. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
Pertussis toxin can inhibit G protein-coupled receptors by ADP-ribosylating the Gi subunit, which may indirectly affect Fpr-rs6 signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 is an inhibitor of MEK, which can block the MAPK/ERK pathway, potentially affecting downstream processes of Fpr-rs6 signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can disrupt the PI3K/Akt pathway, which might be involved in the signaling cascade of Fpr-rs6. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Gö 6983 is a protein kinase C inhibitor that can alter various cellular processes, potentially including those regulated by Fpr-rs6. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 is a p38 MAPK inhibitor that can modify inflammatory responses, which Fpr-rs6 may be a part of. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor that can suppress the PI3K/Akt pathway, thus possibly affecting Fpr-rs6 signaling. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
ML141 is a Cdc42 inhibitor, a small GTPase, which can influence actin cytoskeleton remodeling involved in Fpr-rs6 mediated cell migration. | ||||||
Ro 31-8220 | 138489-18-6 | sc-200619 sc-200619A | 1 mg 5 mg | $92.00 $245.00 | 17 | |
Ro-31-8220 is a broad-spectrum protein kinase inhibitor, including protein kinase C, which can affect signaling pathways linked with Fpr-rs6. | ||||||